Suchergebnisse - "Ogata, Masatomo"

PubPharm (20)

1

Consequences of kidney donation by age in Japanese living kidney donors : a single-center study

enthalten in: Clinical and experimental nephrology | 2024

von Ogata, M. | Osako, K. | Terashita, M. | +6

2

De novo Inflammatory Bowel Disease in Kidney Transplant Recipients : A Single-Center Case Series Study

enthalten in: Inflammatory intestinal diseases | 2024

von Ogata, M. | Kato, M. | Miyauchi, T. | +6

3

Renal anemia with a relatively normal renal function in vasculitis-induced acute tubulointerstitial damage

enthalten in: Renal failure | 2023

von Ogata, M. | Fujii, H. | Sumi, H. | +3

4

Tonicity or serum osmolality? Comment on management of hyperosmolar hyperglycaemic state in adults : An updated guideline from the Joint British Diabetes Societies for Inpatient Care Group

enthalten in: Diabetic medicine : a journal of the British Diabetic Association | 2023

von Ogata, M. | Yazawa, M.

CommentOn: Diabet Med. 2023 Mar;40(3):e15005. - PMID 36370077

5

Giant Simple Kidney Cyst Resulting in Leg Edema Due to Inferior Vena Cava Compression

enthalten in: Internal medicine (Tokyo, Japan) | 2023

von Ogata, M. | Tominaga, N.

6

Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis : An Observational Study

enthalten in: Calcified tissue international | 2023

von Ogata, M. | Sumi, H. | Shiizaki, K. | +1

7

Acute tubulointerstitial nephritis possibly caused by vedolizumab for ulcerative colitis in a kidney transplant recipient : A case report

enthalten in: Clinical nephrology | 2023

von Ogata, M. | Yazawa, M. | Terashita, M. | +2

8

Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study

enthalten in: Calcified tissue international | 2023

von Ogata, M. | Sumi, H. | Shiizaki, K. | +1

9

Tonicity or serum osmolality? Comment on management of hyperosmolar hyperglycaemic state in adults : An updated guideline from the Joint British Diabetes Societies for Inpatient Care Group

enthalten in: Diabetic Medicine | 2023

von Ogata, M. | Yazawa, M.

10

Romosozumab improves low bone mineral density in a postmenopausal woman undergoing chronic hemodialysis and treated with a calcium-sensing receptor agonist

enthalten in: Bone reports | 2022

von Ogata, M. | Ushimaru, S. | Fujishima, R. | +3